|
|
| (11) | Number of the document | C 2205281 |
| (68) | Number of the document | 2205281 |
| (21) | Application number for Supplementary Protection Certificate | PA 2022 013 |
| (22) | Date of filing the application | 2022-11-15 |
| (41) | Date of publication of the application | 2023-01-10 |
| Date of publication of SPC | 2025-09-25 | |
| (24) | Date of coming into effect of SPC | 2028-08-16 |
| (71) |
PharmaEssentia Corp. ,
13F, No. 3. Park St.,
Nangang District,, Taipei 115,
TW
|
| (73) |
PharmaEssentia Corp. ,
13F, No. 3. Park St.,
Nangang District,, Taipei 115,
TW
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/18/1352, 2022-01-31 |
| (94) | 2033-08-15 |
| (95) | alfa-2b ropeginterferonas |
| SPC granted |